Atlas Trials

A Safety,Tolerability and Pharmacokinetics Clinical Trial of JX11502MA Capsule

Clinical trial NCT05233657 · UNKNOWN

Trial details

NCT number
NCT05233657
Sponsor
Zhejiang Jingxin Pharmaceutical Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Schizophrenia
Start date
2020-01-04
Primary completion
2022-01-31
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.